Jan Holmgren

This inventor holds 12 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: Duotol Ab, Scandinavian Biopharma Holding Ab, Vitec Aktiebolag. Active years: 1994-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jan Holmgren. Retrieved from https://idiyas.com/inventor/jan-holmgren

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 4)

% Patents Active = 91.7

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 2.6

ph-index = 5

Forward Citations = 141(Granted Patents)

Location History:

Vastra Frolunda, SE (1994 - 2013)
Västra Frölunda, SE (2001 - 2024)

Company Filing History:

Scandinavian Biopharma Holding Ab

Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd.

Scandinavian Biopharma Holding Ab, C/o Etvax Ab

patent

8. 1 out of 3

Syntello Vaccine Development Kb

patents

Years Active: 1994-2024

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11918636 - Vaccine for protection against ETEC-induced diarrhea comprising dmLT (2024-03-05),

2. 11052143 - Vaccine for protection against ETEC-induced diarrhea comprising dmLT (2021-07-06),

3. 10548961 - Vaccine for protection against ETEC-induced diarrhea comprising dmLT (2020-02-04),

4. 9511133 - [object Object] (2016-12-06),

5. 8506964 - Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosis (2013-08-13),

6. 6322796 - Immunological tolerance-inducing agent (2001-11-27),

7. 6153203 - Immunological tolerance-inducing agent (2000-11-28),

8. 6043057 - Recombinant systems for expression of the cholera B-sub-unit with the (2000-03-28),

9. 5834246 - Recombinant systems for expression of cholera B-subunit with the aid of (1998-11-10),

10. 5681571 - Immunological tolerance-inducing agent (1997-10-28),

11. 5552293 - Tumor antigen specific antibody (1996-09-03),

12. 5346989 - Peptides for use in induction of T cell activation against HIV-1 (1994-09-13),

Title: Jan Holmgren: Pioneering Swedish Inventor

Introduction: Jan Holmgren, a distinguished inventor hailing from Vastra Frolunda, SE, is renowned for his groundbreaking contributions to the field of innovation.

Latest Patents: Jan Holmgren's latest patents include cutting-edge technologies in the realm of sustainable energy solutions and advanced medical devices.

Career Highlights: Throughout his illustrious career, Jan Holmgren has been instrumental in developing revolutionary products that have significantly impacted various industries. His keen eye for detail and innovative approach have led to numerous successful inventions.

Collaborations: Jan Holmgren has collaborated with leading research institutions, universities, and companies worldwide to further his inventions and bring them to the market. His partnerships have been crucial in pushing the boundaries of technological advancement.

Conclusion: Jan Holmgren stands as a beacon of innovation, with a remarkable track record of pioneering inventions that have shaped the landscape of modern technology. His dedication to pushing the boundaries of what is possible continues to inspire future generations of inventors.

Profile summary based on public USPTO records.